Recent Press Releases

ZENALUX COLLABORATES WITH ROSWELL PARK CANCER INSTITUTE TO ENHANCE ZENASCOPE FOR ORAL CANCER DETECTION

ZENALUX COLLABORATES WITH ROSWELL PARK CANCER INSTITUTE TO ENHANCE ZENASCOPE FOR ORAL CANCER DETECTION Enhanced functionality includes imaging capability, autofluorescence DURHAM, NC – APRIL...

Boston Heart Granted New York Laboratory Permit for Diagnostic Testing

Boston Heart Granted New York Laboratory Permit for Diagnostic Testing FRAMINGHAM, Mass., April 17, 2014 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation...

MDxHealth Signs Agreement with Galaxy Health Network PPO Providing Increased Access to ConfirmMDx for Prostate Cancer

MDxHealth Signs Agreement with Galaxy Health Network PPO Providing Increased Access to ConfirmMDx for Prostate Cancer Agreement Increases Access with Additional 3.5 Million Covered Lives IRVINE,...

KineMed Announces Participation in a Global, Multi-Company Effort to Advance and Standardize a Diabetic Research Model

KineMed Announces Participation in a Global, Multi-Company Effort to Advance and Standardize a Diabetic Research Model April 21, 2014 06:00 AM Eastern Daylight Time EMERYVILLE, Calif.--(BUSINESS...

Abbott Reports First-Quarter 2014 Results

Abbott Reports First-Quarter 2014 Results - First-Quarter Ongoing EPS of $0.41, Above Previous Guidance Range of $0.34 to $0.36 (GAAP EPS from Continuing Operations of $0.22) - - Confirms Full-Year...

Cepheid Reports 2014 First Quarter Results

Cepheid Reports 2014 First Quarter Results Strong Commercial and HBDC Drive Clinical Growth of 26% SUNNYVALE, Calif., April 17, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today reported revenues...

The key to easy asthma diagnosis is in the blood

The key to easy asthma diagnosis is in the blood Using just a single drop of blood, a team of UW-Madison researchers has developed a faster, cheaper and more accurate tool for diagnosing even mild...

Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava Blood Tests For Breast Cancer Detection

MIAMI, April 15, 2014 /PRNewswire/ -- Eventus Diagnostics, Inc. (EventusDx) today announced completion of a $2.72 million financing. The financing was led by a new family office private investor, and...

ERBA Diagnostics, Inc. Reports 2013 Financial Results

ERBA Diagnostics, Inc. Reports 2013 Financial Results Revenues increased by 46% and gross profit up by 52% in 2013 compared to 2012 Net income in 2013 compared to net loss in 2012 Third consecutive...

A Dose of Reality About Chemotherapy Dosing -- Saladax Has The Antidote - My5-FU

A Dose of Reality About Chemotherapy Dosing -- Saladax Has The Antidote - My5-FU BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is...

Brain Imaging Tracer for Parkinson's Disease

Brain Imaging Tracer for Parkinson's Disease LA JOLLA, Calif., April 11, 2014 /PRNewswire-iReach/ -- On March 4, 2014, ICB International, Inc., ("ICBI"), announced the development of a...

QIAGEN adds promising new biomarker to pipeline of Personalized Healthcare assays to improve diagnosis of blood disorders

QIAGEN adds promising new biomarker to pipeline of Personalized Healthcare assays to improve diagnosis of blood disorders Reliable diagnostic tools under development for mutations of...

UCLA launches joint venture with Chinese firm to open sophisticated lab in Shanghai

UCLA launches joint venture with Chinese firm to open sophisticated lab in Shanghai Clinical laboratory will provide more accurate diagnoses of cancer and other diseases The University of California...

Philips Handheld Blood Test Shows Further Promise in Clinical Setting

Philips Handheld Blood Test Shows Further Promise in Clinical Setting Prototype of new diagnostic device aims to deliver lab-quality results in less than 10 minutes at patient bedside, holds...

AdvanDx Raises $12 Million to Accelerate the Expansion of the Company's Molecular Diagnostic Product Offerings

AdvanDx Raises $12 Million to Accelerate the Expansion of the Company's Molecular Diagnostic Product Offerings WOBURN, Mass. and VEDBAEK, Denmark, April 8, 2014 /PRNewswire/ -- AdvanDx, Inc....

Adaptive Biotechnologies Announces Completion of Series C and Series D Financing Rounds Through a $105 million Private Investment from Viking Global Investors

Adaptive Biotechnologies Announces Completion of Series C and Series D Financing Rounds Through a $105 million Private Investment from Viking Global Investors Investment fuels expansion of...

Exact Sciences Prices Public Offering of Common Stock

Exact Sciences Prices Public Offering of Common Stock MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced the pricing of an underwritten public offering of 10,000,000...

Roche acquires IQuum to strengthen offerings in molecular diagnostics

Roche acquires IQuum to strengthen offerings in molecular diagnostics IQuum's unique products will allow Roche to quickly enter the point of care segment of molecular diagnostics Roche (SIX: RO,...

Team Identifies Novel Biomarker for Head and Neck Cancer, Non-Small Cell Lung Cancer

Team Identifies Novel Biomarker for Head and Neck Cancer, Non-Small Cell Lung Cancer JUPITER, FL, April 2, 2014 – A team led by a scientist from the Florida campus of The Scripps Research...

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program TUCSON, Ariz., April 3, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a...